At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medication Effects on Periurethral Sensation, Urethral Sphincter Activity and Pressure Flow Parameters
In Brief
A clinical study evaluating Pseudoephedrine, Tamsulosin, and 4 other interventions for Urethral Sphincter Activity. Completed, enrolled 56 participants across 1 site.
Detailed Summary
Lower urinary tract symptoms such as urinary leakage and overactive bladder affect millions of American women. Women may develop these problems because the innervation of the muscles of the bladder and urethra are injured. Most research on treating these problems has focused on the abnormalities of the bladder muscle, but newer studies have shown abnormalities in the innervation and muscle function of the urethra. Women with these symptoms may benefit from treatment with medications to improve their urethral function. However, to truly understand what types of medications will help women with these symptoms, the investigators wish to study how these medications affect innervation and muscle function in healthy women who do not have lower urinary tract symptoms.
Study Details
Timeline
Interventions
Pseudoephedrine ER 120 mg by mouth once daily for 2 weeks
Tamsulosin 0.4mg by mouth daily for 2 weeks
Imipramine 25mg daily by mouth for 2 weeks
Cyclobenzaprine 10mg daily by mouth for 2 weeks
Lactose capsule 1 by mouth daily for 2 weeks
Solifenacin 5mg by mouth daily for 2 weeks